Chapter 6: B-Lymphocytes Development

Development of B Cells

The development of B cells in the bone marrow

-1st of the 6 “broad stages” in the life cycle of B cells

Selection and further development of the B-cell repertoire in secondary lymphoid tissues (blood, lymph nodes, spleen, peyer’s patches)

-2nd, 3rd, 4th, 5th and 6th stages in the life cycle of B cells

1st stage = maturation in the bone marrow (primary lymphoid tissue)

Acquires functional B-cell receptors -Ig gene rearrangements

2nd stage = testing of Ig (B-cell receptor) to normal constituents of the body (self-reactive)

  • Potential for auto reactivity and autoimmune disease

3rd stage = a small fraction of immature B-cells become mature cells in secondary lymphoid tissues

4th stage = recirculation of mature B-cells between the blood, lymph and secondary lymphoid tissues.

5th stage = antigen contact \rightarrow B cell progeny (clonal expansion)

6th stage = differentiate into plasma cells and long-lived memory B cells

Key Processes in B Cell Maturation

Generation (Somatic Recombination)

  • Occurs in the bone marrow.

  • Each B cell undergoes genetic rearrangements to produce a unique antibody.

Negative Selection

  • Removal of B or T cells that recognize self-antigens, establishing tolerance.

  • Critical for preventing autoimmune responses.

Positive Selection

  • Encouragement of cells that can recognize foreign antigens.

  • Final maturation signals received in secondary lymphoid tissue.

Stages of B Cell Development

Stem cell - Ig genes are in the germline configuration

  • Early Pro-B Cell: Identification begins with D-J rearrangements of heavy chain

  • Late Pro-B Cell: V to D-J rearrangement of heavy chain occurs

  • Large Pre-B Cell: Identification of the heavy chain and formation of pre-B cell receptors (pre-BCR).

  • Small Pre-B Cell: V-J Rearrangement of light chain occurs

  • Immature B Cell: Successful light chain gene rearrangement and expression of IgM on the cell surface

  • Mature B Cell: Use of alternative splicing of heavy-chain mRNA to place IgD on the cell surface with IgM, ready for final maturation signals.

T CD4s Involved in B Cell Activation

  • Types of T Helper Cells

    • CD4T helper type 2 (Th2) usually activates B cell growth.

    • CD4 T-Follicular Helper (TFH) activates B cells in the follicles of Lymph nodes where the B cells congregate with Follicular Dendritic Cells (FDCs)

Surrogate Light Chain and Pre-B Cell Receptors

  • Surrogate Light Chains Components

    • Variable Pre-B (VpreB): Surrogate for the variable domain.

    • Lambda 5 (λ5\lambda5): Surrogate for the constant region, known as lambda, important for identification in exams.

  • Developmental Stages

    • Pre-B cell: Large pre-B cell stage: Cells undergo tests to ensure a proper signal Transduction process.

    • Following a successful rearrangement check, the cells proliferate into small pre-B cells.

Signals and Outcomes

  • Signals from the pre-BCR inform on the successful binding of the surrogate light chain, and outcomes include:

    • Stopping production of RAG1/2 somatic recombination

    • Tagging of the RAG2 enzyme for destruction, leading towards allele exclusion.

    • Heavy chain becomes less accessible (closing of DNA)

    • Proliferation of the B cell (rounds of division)

Large pre-B cells → proliferates → producing many small pre-B cells

Small pre-B-cells

  • No longer have pre-B-cell receptor

  • Ig heavy chains are restricted to the cytoplasm

  • Rearrangement of the Ig light-chain loci begins

Central Tolerance/Negative Selection

  • Definition

    • Central tolerance is achieved through negative selection, where self-reactive B cells are eliminated in the bone marrow.

    • Similar processes occur for T cells in the thymus

  • Implications of Neglecting Tolerance

    • Without proper tolerance, there’s a higher risk of autoimmune diseases.

    • Immunocompromised State: Factors such as aging affect overall immune function, leading to increased susceptibility to diseases.

B Cell Maturation Factors

B cells in bone marrow maturation interact with stromal cells which support maturation through growth factor signals like KIT, SCF and IL-7.

Kit on the B cell binds to → stem-cell factor (SCF) on the stromal cell

Activation of Kit causes the B cell to proliferate

B cells at later stage of maturation require interleukin-7 (IL-7) to stimulate their growth and proliferation

Productive vs. Nonproductive Rearrangements

  • Productive Rearrangement

    • Successful gene segments lead to functional BCRs, contributing to survival and normal function.

  • Nonproductive Rearrangement

    • Unsuccessful gene segments that cannot lead to BCR

The two copies are on homologous chromosomes; one inherited from mother and one from father

  • Gene rearrangements can be made on both homologous chromosomes

  • Unproductive rearrangement on one chromosome leads to rearrangement at the locus on the other chromosome

Productive rearrangements → proceed to the next stage of development

If all rearrangements are unproductive → B cell does not produce Ig and dies in the bone marrow

  • Apoptosis

    • ONLY Final nonproductive rearrangements lead to cell apoptosis

Heavy chain rearranged (Late pro-B cell) → large Pre-B cell → κ\kappa Light chain rearrangement → λ\lambda Light chain rearrangemet → Large Pre-B cell

2 copies of each (homologous chromosomes) x 2 light chain types (κ\kappa and λ\lambda) = 4 MINIMUM potential light chain combinations

Further rearrangement within κ\kappa L-chain Loci

After an unproductive rearrangement of Vκ\kappa to a Jκ\kappa, a second rearrangement can be made by any other Vκ\kappa that is on the 5’ (left) side of the first joint with a Jκ\kappa that is on the 3’ (right) side of the first joint

When the second joint is made, the intervening DNA containing the first joint will be excised

There are 5 Jκ\kappa gene segments and many more Vκ\kappa gene segments

  • five successive attempts at productive rearrangement of the κ\kappa L-chain gene on a single chromosome

Success → Stop Mechanisms

Successful gene rearrangement is signaled by the appearance of the protein product of the gene at the cell surface by Igα\alpha and Igβ\beta

  • A signal is sent back to the cell interior to shut down the processes of DNA recombination and repair needed for gene arrangement

  • RAG genes are turned off and no further rearrangement is possible

  • Once heavy-chain gene is successfully rearranged also further rearrangement of heavy-chain genes is shut down

  • Leads to allelic exclusion = same (homogenous) strong product BCR = high avidity

Same process happens with light-chain

Possible outcome if RAG-1 and 2 aren’t shut down after a productive rearrangement in a B-cell → no allelic exclusion giving heterogenous BCRs with low avidity binding

In Late pro-B cells, μ\mu (IgM gene) heavy chains assemble into dimers in the ER

Since this is before light chains, μ\mu heavy-chains assembled into a complex with the λ\lambda 5 and the VpreB polypeptides to form a surrogate L-chain along with Igα\alpha and Igβ\beta and is called a pre-B cell

Checkpoints in Development

Major checkpoints exist during B cell maturation:

Checkpoint 1: Tests heavy chain rearrangement at Large Pre-B Cell

  • The Pre-BCR’s form dimers and oligomers that provide signals to allow maturation to continue.

  • Turns expression of RAG’s off, tags RAG2 for destruction and closes the DNA down = Allelic exclusion at the heavy chain locus

  • Leads to a positive signal that prevents apoptosis and allows B cell to start dividing.

  • After checkpoint, pre-BCR is no longer made, μ\mu heavy chain, Igα\alpha and Igβ\beta continue to be made in ER

  • Result: RAG genes (turned off in dividing Large pre-B cells) are turned on → light chain rearrangement begins

Checkpoint 2: Tests light chain rearrangement at Small Pre-B Cell; can lead to cell death if there is non-rearrangement failure.

  • On completion of a productive light chain gene rearrangement a light chain protein is made and assembles with heavy chain to form IgM

  • IgM (BCR) associates with Igα\alpha and Igβ\beta and is transported to the cell surface

  • Result: Presence of the BCR with Igα\alpha and Igβ\beta tells the cell to halt further light-chain gene rearrangements

Changes in Key Protein Expression

The rearrangement of Ig genes and the expression of pre-BCR and IgM on the cell surface requires several categories of specialized proteins at different times during B-cell development

KIT - present only in stem cell development in bone marrow

IL7 Receptors - present in stem cell development and in Early pro-B Cell

RAG-1/RAG-2 - present in Early pro-B cell and Late pro-B cell (for VDJ recombination of the heavy chain), then turned off, and then turned back on in Small pre-B cell

TdT - Stays on from Early pro-B cell (beginning of heavy chain rearrangement) through Small pre-B cell (rearrangement of light chain)

λ\lambda5 and VpreB - Only active in the Large pre-B cell with the pre-B cell receptor and surrogate chain

Igα\alpha and Igβ\beta - present on B cell surfaces after Late pro-B cell (heavy chain complete)

Translocations and Cancer

Translocations occur only during the first attempt to rearrange a heavy-chain gene

  • This would have counted as an unproductive rearrangement and the other gene would then be rearranged

  • In cases where the 2nd rearrangement is also unproductive, the cell dies and thus cannot give rise to a tumor

  • Mechanism of Translocations

    • Translocations during somatic recombination can lead to oncogenes being misregulated (e.g., MYC gene involved in Burkitt's Lymphoma).

    • Genes from different chromosomes can affect cell cycles, leading to cancerous growth.

  • Key Proto-Oncogenes: Include BCL2 (protective against premature apoptosis in B cells) and MYC

Chromosomal Rearrangements In Burkitt’s Lymphoma

MYC is normally involved in regulating cell division. Abnormal expression as a result of translocation causes increased growth.

  • MYC Gene Location: Chromosome 8.

  • IG heavy Gene Location: Chromosome 14

B1 vs B2 Cell Types

  • B1 Cells: Innate

    • Primarily secretes IgM > IgG without T-cell help.

    • Have a role in the initial immune response, acting via innate mechanisms.

    • Produce antibodies quickly, pre-birth and early after birth, but lack memory.

    • Also known as CD5 B cells

    • Pool of self renewing B-1 Cells established (not required to be in bone marrow)

    • 5% of B cells in body

  • B2 Cells: Adaptive (regular)

    • Primarily secretes IgG > IgM

    • Require T-cell activation to produce antibodies and are involved in adaptive immunity.

    • Able to engage in somatic hypermutation and class switch recombination for diverse antibody production.

    • Have memory and are located in secondary lymphoid tissues but replaced from bone marrow

    • 95% of B cells in body

Negative Selection for Self-Reacting B Cells

Quality control mechanisms prevent the maturation of B cells whose receptors bind normal components of the human body – called self-antigens (protein, carbohydrates, lipids found on the surface of human cells.

  • Immature B cells that do not encounter a self-antigen leave the bone marrow and enter the peripheral circulation expressing both IgM and IgD on their surface

Immature B cells that bind soluble self-antigens (monovalent self-antigens) are rendered unresponsive or anergic (or unresponsive) to the antigen

When a developing B cell produces surface IgM that are strongly cross-link by multivalent self-antigens (MHC complex molecule on cell surfaces) the B cell undergoes receptor editing

  • The amount of IgM on the surface is reduced and the RAG genes are not turned off

  • Continued synthesis of RAG proteins allow the cell to continue L-chain gene rearrangement

  • Usually leads to a new productive rearrangement and expression of a new L-chain which combines with the previous H-chain to form a new receptor (receptor editing)

Receptor Editing in B Cells

  • B cells can undergo receptor editing if they recognize self-antigens (multivalent) during maturation:

    • Receptor editing allows changes to the light chain of the BCR to avoid autoimmunity.

If this new receptor is not self-reactive the cell is “rescued” and continues normal development much like a cell that had never reacted with self

If the cell remains self-reactive, it may be rescued by another cycle of rearrangement but if it continues to react strongly with self it will undergo apoptosis and be deleted from the repertoire

Lymph Node Circulation/Activation

In a lymph node, there are discrete sites for B cells and T cells.

  • Expansion of effector B cell region (plasma cells that secrete antibodies) occurs in lymphoid follicles.

  • As lymphocyte development proceeds, follicle shape changes - germinal center

From the bone marrow, an immature B cell (high IgM, no IgD) will migrate via the blood to the secondary lymphoid organs, directed by cytokines

  • CCL19 and CCL21: Guide B cells into lymph node, bind to CCR7

B cells enter the cortex of the lymph node through the wall of specialized high endothelial venules (HEV), also directed by cytokines

  • CXCL13: Draws B cells into follicular areas during migration, binds to CCXR5

Late immature or transitional (IgD increasing close to maturity) B cell then interacts with Follicular dendritic cells to receive their final signal to fully mature and survive.

  • BAFF: B Cell Activating Factor released by Follicular Dendritic Cell

Result: Now called naïve B-cells (mature). Immature B-cells that fail to enter the follicle will die.

Secondary lymphoid tissue follicles are the sites where mature, naïve B cells encounter specific antigen (held on Follicular Dendritic Cells)

Antigen-specific B cells stay in the T-cell areas, and are activated by antigen-specific, CD4 helper T cells

  1. The B cell binds the antigen on the FDC.

  2. The B cell internalizes the antigen.

  3. It processes it and presents peptide on MHC II.

  4. The B cell then moves to the T-B border to get help from CD4 T cells.

  5. CD4 T cells (TFH and TH2) provide signals that activate the B cells to proliferate and differentiate

  • Both Th2 and T-Follicular Helper (TFH) cells secrete IL-4, which drives isotype switching to IgE

Somatic Hypermutation and isotype switching happen after B cells receive help from CD4 T cells

  • In lymph nodes and spleen some of the activated B cells immediately proliferate and differentiate into plasma B cells and secrete antibody (lower affinity)

  • Other activated B cells migrate to a primary follicle that matures into a secondary follicle containing a germinal center

Primary Follicle (Before Infection)

When a B cell recognizes antigen and receives help from CD4 T cells, the follicle becomes activated \rightarrow Secondary Follicle Forms (with germinal center) and undergoes proliferation

Germinal Center

Dark Zone(dark stains): B cells = centroblasts

  • proliferation,

  • somatic hypermutation (higher/lower/same binding site affinity)

  • isotype switching

Light Zone (light stains): B cells = Centrocytes and also containes Follicular Dendritic Cells

  • B cells that mature into non-dividing centrocytes that have undergone isotype switching and somatic hypermutation

  • Retesting BCR

  • Centrocytes compete for original antigen on FDCs to test which one is best

Selection After Affinity Maturation

Cells that survive the selection process after affinity maturation undergo further proliferation and migrate from the germinal center to other sites in the secondary lymphoid tissues or bone marrow

  • Selected B cells differentiate into plasma cells secreting high affinity, isotype-switched antibody

  • As immune response subsides, germinal center B cells develop into memory B cells capable of making high affinity antibody when re-exposed to the same antigen (basis of secondary immune response)

At end of infection, less antigen is available. Memory B cells have the strongest affinity Igs on their surface

B Cell Population Dynamics

No follicle visit \rightarrow die (typically less than a week)

Follicle visit \rightarrow unless stimulated by specific-Ag \rightarrow die (mature B cell can live for weeks)

B Cell Half Life: 3-8 weeks for B cell

  • B cell has to constantly get BAFF signal in order to survive and maintain its population within the immune system.

  • This critical signal ensures that B cells continue to proliferate and differentiate, allowing for a robust and responsive immune response during infection

As infection ends

  • Most B cells die of apoptosis as amount of antigen lowers

  • Some remain as memory cells, providing long-lasting immunity by quickly responding to future infections with the same antigen

Adaptive Immune Responses of Mature B2_2 Cells

3 ways to differentiate into Plasma B cells (antibody secreting)

Primary Adaptive Immune Response

  • Activated B cells differentiate into plasma cells which produce only IgM antibodies specific to the encountered antigen, thereby initiating the body’s defense mechanism.

  • Centrocytes (post somatic hypermutation and isotype switching) also differentiate into plasma cells

Secondary Adaptive Response

  • Memory B cells differentiate into plasma cells which produce antibodies specific to the remembered antigen